//Your Connection to the Life Sciences Industry
Connect to IBC:LinkedIn iconTwitter iconFacebook iconBlog iconRSS icon
EmailPrint

Registration

Online Registration is Open!
Register by Friday, January 23, 2015 to Save $400 off standard rates.
»Pricing Chart

Watch 2014 Keynotes

Add to Outlook Calendar

Find Another IBC Event

TIDES: Oligonucleotide and Peptide Therapeutics from Research through Commercialization

CSS

Agenda CSS

Access the hottest fields in therapeutics by attending TIDES - the only event with full coverage of discovery, development and manufacturing

May 03-06, 2015
Town and Country Resort Hotel
San Diego, CA

Event Overview

Event Overview

2015 Keynote Speakers Confirmed!

Stanley T. Crooke, M.D., Ph.D.

Antisense Technology: Current Status and Future
Stanley T. Crooke, M.D., Ph.D.
Chief Executive Officer, Isis Pharmaceuticals, Inc.

John Maraganore, Ph.D.

Progress in Advancement of RNAi Therapeutics
John Maraganore, Ph.D.
Chief Executive Officer, Alnylam Pharmaceuticals

Town and Country Hotel

Mark Your Calendar

TIDES 2015
May 3-6, 2015
Town and Country Hotel
San Diego, CA

2014 Highlights

2014 Speaker Interviews

Jeffrey Baker, Ph.D.; David C. Blakey, Ph.D.; Jared A. Gollob, M.D.; and Eric von Hofe, Ph.D.

» Watch TIDES 2014 Speaker Interviews

TIDES 2014 photo TIDES 2014 photo TIDES 2014 photo

View Photos from TIDES 2014!

» TIDES 2014 Event Guide Now Available

From Discovery to Manufacturing, Get the Information You Need to Advance your Research, Development and Process Chemistry

Join 750 global oligonucleotide and peptide professionals at TIDES 2014, where you will access the latest science, technologies and regulations needed to advance your product from discovery to clinic to market.

Our 2014 program includes tons of exciting new updates, speakers and topics to keep you on the pulse of this evolving industry. Whether your focus is on oligonucleotides or peptides, discovery or manufacturing, TIDES 2014 is the one-stop conference to advance your research, development and process chemistry efforts forward.

brochure cover

Brochure Now Available
» Download Today!

TIDES Pre-Event Podcasts Now Available!
» Learn More

TIDES 2013 Keynote Presentations Now Available!
» Learn More

Oligonucleotides

Manufacturing

Efficiently scale-up manufacturing by hearing industry best practices to reduce your cost of goods, implement new process validation guidelines and conjugate your molecule for increased market share

Discovery

Learn how to design oligonucleotides with better drug-like properties and hear about preclinical and clinical successes and challenges of multiple siRNAs, miRNAs, aptamers, LNAs and antisense molecules

Peptides

Manufacturing

Accelerate your process development efforts by effectively implementing the latest process validation guidelines and overcoming complicated formulation and manufacturing challenges

Discovery

Accelerate new molecules to clinic by exploring new frontiers in peptide discovery and benchmark your portfolio by hearing the latest preclinical and clinical data on peptides currently in development

Accelerate Your Therapeutic from Discovery to Clinic to Market

Accelerate Your Pipeline and Improve Your Manufacturing Operations
by accessing case studies, regulatory updates and lessons learned from 100 industry and academic presentations

Benchmark Your Current Development Efforts
by hearing preclinical and clinical successes and failures from peptides and oligonucleotides currently in development

Access Novel Technologies and Cutting-Edge Science
in the exhibit and poster hall, featuring over 75 exhibitors and 30 peer-submitted posters

Forge Scientific and Business Partnerships
by meeting 750 global oligonucleotide and peptide professionals during networking luncheons, cocktail receptions and refreshment breaks

Testimonials

"TIDES is the premier venue to network with the experts in peptide and oligonucleotide development and to be on the pulse of current status and future trends in Biotech and Pharma." - Alex Fӓssler, Ph.D., COO Europe, Bachem AG, Switzerland

"TIDES is an excellent opportunity to connect with the Oligo Industry, staying abreast of the latest developments while formulating strategies for the future." - Giuseppe Whelan, Project Leader, GlaxoSmithKline

"One of the great things about TIDES, in addition to the excellent program content, is the large exhibit hall which enables me to meet with many of the most relevant suppliers with just one trip." - Christoph Rosenbohm, Ph.D., Senior Director, Research Operations, Santaris Pharma A/S, Denmark

"Very interesting presentations from industry and academia make TIDES an excellent opportunity to know the hot-topics in peptide therapeutics. The dynamic, friendly atmosphere creates good networking opportunities." - Jose De Chastonay, Ph.D., MBA, Chief Marketing Officer, Bachem Group

"TIDES is THE venue for oligonucleotides and peptides together. The complete package only exists in one setting and that's TIDES. There is no forum that has the same level of expertise in one place at one time other than TIDES." - Scott Petersen, Ph.D., Chief Scientific Officer, Liposciences, Inc.